stockrow
Friday 6 November 2026
Export CAH’s income statement to Excel — free account
Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025.
- Revenue
- +5.47%
- EPS
- +26.3%
- Free cash flow
- +10.9%
- Total debt
- −2.40%
Quarter to September 2026, against a year earlier
267.66
5.73
+2.19%
Follow CAH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
29.40 | 32.16 | 32.72 | 28.68 |
P/S ratio |
0.20 | 0.20 | 0.22 | 0.20 | |
P/FCF ratio |
8.76 | 11.25 | 12.31 | 11.33 | |
P/Operating CF |
70.70 | 27.24 | 33.13 | 30.51 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.22 | 0.22 | 0.24 | 0.21 | |
EV/EBITDA |
16.03 | 16.88 | 16.84 | 15.04 | |
EV/Operating CF |
8.98 | 10.92 | 11.61 | 10.66 | |
EV/FCF |
9.89 | 12.37 | 13.19 | 12.11 | |
Quick Ratio |
0.38 | 0.42 | 0.43 | 0.43 | |
Current Ratio |
0.91 | 0.91 | 0.88 | 0.88 | |
Net Debt/EBITDA |
6.64 | 6.58 | 4.15 | 3.55 | |
Debt/Assets |
15.54% | 15.73% | 15.51% | 14.80% | |
Debt/Equity |
(3.34) | (3.34) | (3.26) | (3.08) | |
Asset Turnover |
4.66 | 4.71 | 4.61 | 4.49 | |
Operating CF/Net income |
1.47 | 4.57 | 4.25 | 0.00 | |
Capex/Depreciation |
(0.43) | (0.59) | (1.10) | 0.00 | |
Interest Coverage |
8.03 | 5.04 | 9.23 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.39% | 2.71% | 2.62% | 0.00% | |
Intangible Assets out of Total Assets |
0.24 | 0.24 | 0.24 | 0.23 | |
Share Based Compensation of Revenue |
0.13% | 0.21% | 0.09% | 0.16% | |
Graham Net Nets |
(0.44) | (0.43) | (0.38) | (0.41) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
3.40% | 3.11% | 3.06% | 3.49% | |
Free Cash Flow Yield |
11.41% | 8.89% | 8.13% | 8.83% | |
Revenue per Share |
278.08 | 259.32 | 269.80 | 291.00 | |
Operating CF per Share |
2.91 | 7.76 | 7.17 | 0.00 | |
Capex per Share |
(0.42) | (0.62) | (1.12) | 0.00 | |
Free Cash Flow per Share |
2.48 | 7.14 | 6.05 | 0.00 | |
Cash per Share |
11.77 | 16.75 | 20.58 | 22.69 | |
Shareholders Equity per Share |
(11.44) | (11.37) | (11.54) | (12.35) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(11.44) | (11.37) | (11.54) | (12.35) | |
Free Cash Flow |
586.00 | 1,677.00 | 1,428.00 | — | |
Working Capital |
(4,084.00) | (3,925.00) | (5,151.00) | (5,336.00) | |
Capital Expenditures |
(100.00) | (146.00) | (264.00) | — | |
Net Current Asset Value |
(21,553.00) | (21,297.00) | (21,270.00) | (21,420.00) | |
EV/EBIT |
21.61 | 23.63 | 23.00 | 20.45 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
19.15 | 21.48 | 21.46 | 19.13 | |
| Other line items | |||||
Average Receivables |
13,015.50 | 13,157.00 | 13,528.50 | 14,156.00 | |
Average Payables |
35,147.00 | 35,323.00 | 36,498.00 | 38,898.50 | |
Average Inventory |
18,510.00 | 17,082.50 | 17,064.00 | 17,977.00 | |
Average Assets |
52,542.50 | 53,280.00 | 55,210.50 | 57,386.00 | |
Average Common Equity |
(2,810.50) | (2,285.00) | (2,679.00) | (2,798.50) |
Columns are period end dates · fundamentals updated 5 Nov 2026